Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI)
RANI Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
270.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
395.40%
RANI Stock Analysis
RANI
PE Ratio:
RANI
PEG Ratio:
Not Available
RANI
Forward EPS Growth (12 month):
0.00%
RANI
PS Ratio:
18
RANI
PSG Ratio:
0.1
RANI
Forward Revenue Growth (12 month):
303.80%
RANI Articles
No data was found